Close Menu

NEW YORK (GenomeWeb) – In a filing with the US Securities and Exchange Commission last week, CareDx announced that its CareDx Pty subsidiary had agreed to purchase from Illumina affiliate Conexio Genomics certain property and assets related to HLA typing for sequencing using capillary electrophoresis-based methods.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.